Yen Stalls as Japanese Retail Investors Hesitate in Uncertain Market Environment ADP Employment Data Points to Steady but Measured Labor Market Gains Los Angeles Dodgers 182 Million Loss Highlights Financial Risks in MLB Pitcher Recovery Cycles Chinas DeepSeek AI Claims Breakthrough in LowCost Model Training Without Advanced Chips ADP Reports Private Payrolls Rise by 109000 in April Exceeding Expectations Signals Stable Labor Market Piper Sandler Warns Prolonged Strait of Hormuz Closure Could Drive Oil to Record Highs ABCL Q1 2026 Earnings EPS Surprises to the Upside as Biotech Continues Development DLR Q1 2026 Earnings Slight EPS Beat Amid Steady Data Center Demand HALO Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick ASTI Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Zoetis ZTS Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Performance Johnson Controls JCI Q1 2026 Earnings EPS Beats Estimates by Over 5 Amid Mixed Market Reaction SoundHound AI SOUN Holds Near Key Support After Modest Decline Ryder System R Slips Slightly Consolidation Near Resistance Levels Vision Marine Technologies VMAR Faces Selling Pressure After DoubleDigit Decline FG Nexus Inc FGNX Slides 186 as Key Support Levels Come into Focus MGM Resorts Edges Higher Amid Cautious Market Sentiment Novartis Raises Annual Sales and Profit Guidance Amid Strong Operational Momentum Offer for Sale OFS Explained A Guide to How It Works on Stock Exchanges Torrent Pharma Reports 26 Drop in Q4 Profit Amid JB Pharma Acquisition Costs and Severance Board Approves 5000 Crore QIP Morgan Stanley Downgrades Aegon to Equal Weight on Valuation Concerns French Investors Shift to Real Assets as Safe Haven in First Quarter Beyond Inc to Acquire Buy Buy Baby Brand Rights Reuniting with Bed Bath Beyond KALU Q1 2026 Earnings Massive EPS Beat Drives Stock Higher Amid Strong Operational Execution QSR Stock Holds Steady as Restaurant Brands International Navigates Market Conditions ELS Q1 2026 Earnings Modest EPS Beat and Steady Market Response LGN Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction CMRC Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines GALT Q1 2026 Earnings EPS Misses Estimates as Clinical Development Continues SERV Q1 2026 Earnings EPS Misses on WiderThanExpected Loss CNTB Q1 2026 Earnings Deeper Than Expected Losses as Biotech Continues PreRevenue Phase FNLC Q1 2026 Earnings EPS of 080 Reported Stock Edges Up Amid Sparse Disclosure